Latest news
Announcement R&D Training to Korean Pharm & Biotech Industries, KDRA, Seoul, Korea, 13-15 June 2011
Kinesis Pharma, in collaboration with the Korean Drug Research Association (KDRA), will organize a 2-days course in Drug Development for the Korean Pharmaceutical & Biotech Industry. The course will be followed by 2 days of consulting and will take place in Seoul, Korea, from June 13-17, 2011. The course is supported by the Korean Ministry of Health & Welfare, Korea Health Industry Development Institute (KHIDI) and SCH BioPharm Human Resources Development Center.
The course will guide the participant through the drug development process from discovery up to filing, with focus on early drug development. The following topics will be discussed: Discovery and Late-lead Optimization, Non-Clinical Development, Pharmaceutical Development, Bridging Non-Clinical to Clinical Development, Early Clinical Development/Phase I and Pharmacokinetics, Regulatory, Biopharmaceuticals: Key Differences with Small Molecules, and Project Management.
Course leaders will be Ms. Annemiek Stijnen, PhD, Director CMC, and Ms. Patricia Baede, MSc, Director Regulatory Affairs from the headquarters in Breda, The Netherlands, and Mr Kees Bol, PhD, General Manager of the regional office in Singapore. Please send an email to info@kinesis-pharma.com.sg if you like to receive further information on this event.
Download: Official Announcement Document of R&D Training Program(June 13-15).pdf
- 23/05/2012 - 2nd Annual Course on Drug Development in Seoul, Korea, May 23-24 2012
- 02/04/2012 - Endorsement of complicance to the OECD GLP guidelines for NCDSER/Innostar, China
- 19/03/2012 - Kinesis visits Wecome Medicine Industry, China
- 28/02/2012 - Kinesis Pharma supports two more Chinese labs to become OECD GLP compliant
- 30/01/2012 - Kinesis consultants registered as pharmaceutical medicine specialists at the NVFG.
- 16/01/2012 - Kinesis Pharma will prepare a paediatric investigational plan for a compound for treatment of an orphan disease.
- 28/10/2011 - Successful course on registration of traditional herbal medicinal products in EU for a Chinese company
- 10/10/2011 - New assignments in China
- 10/10/2011 - Phase III protocol receives FDA approval based on submission and data generated by Kinesis
- 28/09/2011 - Kees Bol, CEO Kinesis Pharma Singapore, Invited Speaker at BIO KOREA, 28-30 September 2011
- 26/09/2011 - New endorsement of compliance from the Dutch GLP Inspectorate
- 08/09/2011 - Kees Groen speaker at Expert Workshop (NMC & NBIC in co-creation with LURIS), September 8th 2011
- 02/09/2011 - CSForum "Innovative Technology" at Kinesis Pharma B.V.
- 01/09/2011 - New personnel from September 1st 2011!
- 04/08/2011 - Kees Bol (CEO Kinesis Pharma Singapore) speaker at seminar Exploit Technologies, Singapore
- 21/06/2011 - Kinesis Pharma trains Korean Pharm & Biotech Industries (KDRA)
- 13/06/2011 - Announcement R&D Training to Korean Pharm & Biotech Industries, KDRA, Seoul, Korea, 13-15 June 2011
- 26/05/2011 - Kinesis Pharma Singapore in online e-journal of PACRA
- 23/05/2011 - MicroConstants Beijing obtains OECD GLP accreditation for bioanalytical services.
- 01/05/2011 - Mike Ugwoke, Ph.D. starts as Senior Consultant CMC
- 01/12/2010 - Mymetics HIV Vaccine Shows Strong Preliminary Phase I Data
- 25/10/2010 - Successful Kinesis Pharma Seminar on October 8th 2010
- 06/10/2010 - Kinesis submits eCTD-IND for new combination product to FDA .
- 06/10/2010 - Kinesis Pharma and the Medicines for Children Research Network (MCRN)
- 06/10/2010 - Kinesis presents poster at 6th Int. Symposium on Measurement and Kinetics of In Vivo Drug Effects
- 01/09/2010 - Press Release: Kinesis Pharma BV (Kinesis) appoints new Chief Operating and Scientific Officer
- 01/08/2010 - Kinesis Pharma opens office in Singapore
- 26/06/2010 - Sino-Foreign Giants: Globalization is a trend in the biomedical industry in China
- 24/06/2010 - Westernization of Chinese pharmaceuticals, but do not forget Traditional Chinese Medicine (TCM)